BeStock  
Stocks › Biotechnology › CRMD

CorMedix CRMD

US equityMarket cap rank #3658Biotechnology
$7.28 +$0.00 (0.00%)
Pre-market · Oct 8, 9:00 am ET · After hours $7.30 +0.28%
Open$7.27
Prev close$7.28
Day range$7.18 – $7.31
Volume833.1K
Market cap$567.43M
P/E (TTM)3.3
Dividend yield–

Fundamentals

Latest reported quarter: Q2, ended Jun 2026

Revenue$99.31M+149.9% YoY
Operating profit$42.91M+119.6% YoY
Net profit$25.99M+31.1% YoY
Diluted EPS$0.29+3.6% YoY
Free cash flow$85.68M+185.9% YoY
Operating cash flow$86.24M

Revenue, last 8 quarters

$11.5MSep '24$31.2MDec '24$39.1MMar '25$39.7MJun '25$104.3MSep '25$128.6MDec '25$127.4MMar '26$99.3MJun '26

Net profit, last 8 quarters

$-2.8MSep '24$13.5MDec '24$20.6MMar '25$19.8MJun '25$108.6MSep '25$14.0MDec '25$38.6MMar '26$26.0MJun '26

Diluted EPS by quarter

-0.05Sep '240.22Dec '240.30Mar '250.28Jun '251.26Sep '250.16Dec '250.43Mar '260.29Jun '26

Free cash flow by quarter

$-13.7MSep '24$-5.6MDec '24$19.7MMar '25$30.0MJun '25$30.4MSep '25$92.7MDec '25$41.7MMar '26$85.7MJun '26

Annual revenue

$239.2KFY20$190.9KFY21$65.4KFY22$0.0FY23$43.5MFY24$311.7MFY25

Profitability & balance sheet

Gross margin82.6%
Operating margin47.5%
Net margin40.7%
Return on equity54.6%
Return on assets32.2%
Return on invested capital45.0%
Current ratio2.56
Liabilities / assets49.0%
Cash & investments$256.69M
Total debt$145.15M
Net cash (debt)$111.54M
Free cash flow / sales54.8%

Where the revenue comes from

Quarter 2026/Q2

By business line

  • DefenCath$66.12M 66.6%
  • Melinta Portfolio$28.22M 28.4%
  • Contract revenue$4.97M 5.0%

Income statement

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Total Operating Revenue $99.31M $127.43M $311.71M $128.62M $104.28M
Cost of Revenue $24.81M $22.31M $35.96M $21.31M $11.19M
Gross Profit $74.50M $105.12M $275.75M $107.31M $93.08M
Operating Expense $31.59M $41.46M $125.61M $48.18M $41.73M
Selling and Admin Expenses $27.53M $34.25M $106.27M $39.58M $36.64M
-Selling & Marketing Expense $12.45M $12.53M $38.05M $16.01M $11.19M
-General & Admin Expense $15.09M $21.72M $68.22M $23.57M $25.45M
Research & Development $6.68M $7.21M $19.33M $8.60M $5.10M
Other Operating Expenses -$2.62M – – – –
Operating Profit $42.91M $63.66M $150.14M $59.13M $51.35M
Other Income (Expense) -$4.18M -$8.01M -$1.19M -$1.75M $618,182.00
Gain on Sale of Security $2.55M -$3.55M $5.31M $2.35M $3.02M
Special Income (Charges) -$6.65M -$4.20M -$6.50M -$4.10M -$2.40M
-Less:Restructuring and Mergern & Acquisition $6.65M $4.20M $6.50M $4.10M $2.40M
Other Non-Operating Income (Expenses) -$71,000.00 -$268,000.00 – – –
Pretax Profit $38.73M $55.65M $150.02M $56.45M $52.58M
Tax $12.75M $17.04M -$13.04M $42.43M -$55.99M
Net Profit $25.99M $38.60M $163.06M $14.02M $108.56M
Profit from Continuing Operations $25.99M $38.60M $163.06M $14.02M $108.56M
Net Income to Parent Company $25.99M $38.60M $163.06M $14.02M $108.56M
Net Income to Common Stockholders $25.99M $38.36M $162.07M $13.03M $108.56M
Basic EPS $0.33 $0.48 $2.25 $0.18 $1.42
Diluted EPS $0.29 $0.43 $2.04 $0.16 $1.26
Total Revenue as Reported – $127.43M $311.71M $128.62M $104.28M
Other Preferred Stock Dividends – $241,000.00 $988,000.00 – –
Net Non-Operating Interest Income (Expense) – – $1.06M -$927,098.00 $612,030.00
Non-Operating Interest Income – – $3.85M $889,981.00 $1.56M
Non-Operating Interest Expense – – $2.78M $1.82M $948,242.00

Balance sheet

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Total Assets $904.05M $815.64M $826.14M $826.14M $750.86M
Total Current Assets $480.55M $383.11M $367.05M $367.05M $259.54M
Cash and Cash Equivalents & Short-Term Investments $256.69M $178.09M $148.53M $148.53M $55.72M
-Cash and Cash Equivalents $256.69M $178.09M $144.84M $144.84M $48.49M
-Short Term Investments $0.00 $0.00 $3.69M $3.69M $7.22M
Receivables $161.31M $154.81M $171.23M $171.23M $160.07M
-Accounts Receivable $161.31M $154.81M $171.23M $171.23M $158.57M
Inventory $38.58M $30.73M $29.72M $29.72M $28.92M
Restricted Cash $656,000.00 $656,000.00 $656,000.00 $656,000.00 –
Other Current Assets $23.32M $18.83M $7.86M $7.86M $5.59M
Total Non-Current Assets $423.50M $432.52M $459.09M $459.09M $491.33M
Net PPE $7.85M $6.17M $8.98M $8.98M $7.52M
-Gross PPE $7.85M $6.17M $8.98M $8.98M $7.52M
Goodwill and Other Intangible Assets $388.47M $398.77M $409.07M $409.07M $407.53M
-Goodwill $30.00M $30.00M $30.00M $30.00M $17.52M
-Other Intangible Assets $358.47M $368.77M $379.07M $379.07M $390.01M
Non-Current Deferred Assets $0.00 $3.31M $16.28M $16.28M $52.50M
Other Non-Current Assets $27.17M $24.27M $423,000.00 $423,000.00 $1.72M
Total Liabilities $443.22M $378.59M $420.84M $420.84M $376.73M
Total Current Liabilities $187.40M $128.78M $174.27M $174.27M $133.64M
Payables $23.29M $29.67M $21.45M $21.45M $26.28M
-Accounts Payable $10.24M $12.83M $7.88M $7.88M $20.45M
-Total Tax Payable $13.05M $16.84M $12.76M $12.76M $4.22M
Current Accrued Expenses $153.17M $91.30M $146.07M $146.07M $102.99M
Other Current Liabilities $10.94M $7.81M $5.31M $5.31M $2.95M
Total Non-Current Liabilities $255.82M $249.81M $246.57M $246.57M $243.09M
Long Term Debt and Capital Lease Obligation $145.15M $144.89M $147.47M $147.47M $147.50M
-Long Term Debt $145.15M $144.89M $144.63M $144.63M $144.53M
Non-Current Deferred Liabilities $663,000.00 – – – –
Other Non-Current Liabilities $110.01M $104.93M $99.10M $99.10M $95.59M
Total Equity $460.83M $437.05M $405.31M $405.31M $374.13M
Stockholders' Equity $460.83M $437.05M $405.31M $405.31M $374.13M
Capital Stock $78,000.00 $78,000.00 $79,000.00 $79,000.00 $78,442.00
-Common Stock $78,000.00 $78,000.00 $79,000.00 $79,000.00 $78,350.00
-Preferred Stock $0.00 $0.00 $0.00 $0.00 $92.00
Additional Paid-In Capital $572.74M $574.94M $581.80M $581.80M $564.56M
Retained Earnings -$111.99M -$137.97M -$176.58M -$176.58M -$190.60M
Gains/Losses Not Affecting Retained Earnings $2,000.00 $2,000.00 $3,000.00 $3,000.00 $87,640.00
Prepaid Assets – – $9.05M $9.05M $9.24M
Investments and Advances – – $10.36M $10.36M $8.09M
-Available for Sale Securities – – $10.36M $10.36M $8.09M
Non Current Accounts Receivables – – $946,000.00 $946,000.00 $864,549.00
Non-Current Prepaid Assets – – $13.03M $13.03M $13.10M
-Other Payable – – $804,000.00 $804,000.00 $1.61M
Short-Term Debt and Capital Lease Obligation – – $1.45M $1.45M $1.42M
-Current Capital Lease Obligation – – $1.45M $1.45M $1.42M
-Long Term Capital Lease Obligation – – $2.84M $2.84M $2.97M
-Other Receivables – – – – $1.49M

Cash flow

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Operating Cash Flow $86.24M $42.38M $175.05M $94.46M $30.86M
Net cash flow from continuing operations $86.24M $42.38M $175.05M $94.46M $30.86M
Net Income from Continuing Operations $25.99M $38.60M $163.06M $14.02M $108.56M
Depreciation & Depletion & Amortization $10.54M $10.54M $14.55M $10.43M $3.79M
Deferred Tax $3.98M $12.96M -$25.80M $33.89M -$59.69M
Other Non-Cash Items $7.60M $4.65M $7.28M $4.33M $2.87M
Change in Working Capital $36.60M -$32.51M $7.33M $30.31M -$25.65M
-Change in Receivables -$6.43M $16.45M -$90.92M -$12.40M -$87.27M
-Change in Inventory -$7.85M -$1.02M -$3.48M -$800,120.00 -$642,880.00
-Change in Prepaid Assets -$5.09M -$2.26M -$2.06M -$1.36M $1.11M
-Change in Payables and Accrued Expense $56.19M -$45.68M $104.10M $45.01M $61.31M
Net cash flow from investing -$561,000.00 $2.97M -$308.43M $3.30M -$291.32M
Net Cash Flow from Continuing Investing Activities -$561,000.00 $2.97M -$308.43M $3.30M -$291.32M
Net PPE Purchase and Sale -$561,000.00 -$729,000.00 -$2.26M -$1.72M -$505,896.00
Net Investment Purchase and Sale $0.00 $3.69M $2.34M $3.53M $19.19M
Financing Cash Flow -$7.07M -$12.10M $238.45M -$1.41M $150.53M
Net Cash Flow from Continuing Financing Activities -$7.07M -$12.10M $238.45M -$1.41M $150.53M
Net Common Stock Issuance -$6.39M -$11.09M $90.16M $1.03M $3,173.00
Proceeds from Stock Option Exercised $235,000.00 $1.18M $6.39M $3.59M $1.32M
Net Other Financing Charges -$914,000.00 -$2.18M -$8.09M -$6.03M -$796,129.00
Ending Cash Balance $257.68M $179.08M $145.83M $145.83M $49.48M
Net Change in Cash $78.61M $33.25M $105.07M $96.35M -$109.93M
Beginning Cash Balance $179.08M $145.83M $40.76M $49.48M $159.41M
Effect of Exchange Rate Changes $0.00 $0.00 $0.00 -$1,333.00 $333.00
Free Cash Flow $85.68M $41.65M $172.79M $92.74M $30.35M
Gain/Loss from Continuing Operations – – -$86,000.00 – –
-Change in Other Current Liabilities – – -$308,000.00 -$149,567.00 –
Net Business Purchase and Sale – – -$308.51M $1.49M –
Net Issuance Payments Of Debt – – $150.00M $0.00 –

Discussion

No comments yet — be the first to weigh in on CRMD.

Leave a comment

Scroll to Top